文献速递胰腺与胆道疾病

慢性胰腺炎患者中小肠细菌过度生长常见,并与糖尿病、慢性胰腺炎严重程度、低锌水平及阿片类药物使用相关

Small Intestinal Bacterial Overgrowth Is Common in Chronic Pancreatitis and Associates With Diabetes, Chronic Pancreatitis Severity, Low Zinc Levels, and Opiate Use.
PubMed 文献 · Am J Gastroenterol · 2019-01-01

该研究回顾性纳入1989至2017年间273例疑似慢性胰腺炎且接受葡萄糖呼气试验的患者,其中98例确诊慢性胰腺炎,40.8%存在小肠细菌过度生长(SIBO)。单因素分析中阿片类药物使用、糖尿病、Mayo总分、锌和 albumin 与SIBO相关,多因素分析仅锌水平为独立预测因子(OR=0.0001,P=0.03)。

要点

  • 无上消化道手术的慢性胰腺炎患者中,经葡萄糖呼气试验诊断的SIBO发生率为40.8%。
  • 锌水平是SIBO的独立预测因子(OR=0.0001,P=0.03)。
  • 阿片类药物使用、糖尿病及Mayo评分升高应提高对SIBO的临床怀疑。

核心结论

  • 无上消化道手术的慢性胰腺炎患者中,经葡萄糖呼气试验诊断的SIBO发生率为40.8%。
  • 慢性胰腺炎更严重的标志(低锌水平、糖尿病和Mayo评分升高)及阿片类药物使用应提高对SIBO的临床怀疑,尤其在持续脂肪泻或体重下降且接受胰腺酶替代治疗的患者中。

研究设计与样本

  • 回顾性研究,纳入1989至2017年间273例年龄≥18岁、疑似慢性胰腺炎并接受葡萄糖呼气试验的患者。
  • 慢性胰腺炎按Mayo评分(0-16分)≥4分定义,SIBO按罗马共识标准以葡萄糖呼气试验阳性定义。
  • 回顾性收集5个先验变量(年龄、阿片类药物、酒精使用、糖尿病、胃轻瘫)和41个研究变量。
  • 98例确诊慢性胰腺炎,其中40.8%存在SIBO。

主要发现

  • 273例中98例确诊慢性胰腺炎,40.8%存在SIBO。
  • 46个变量中5个预测SIBO:阿片类药物(P=0.005)、糖尿病(P=0.04)、Mayo总分(P<0.05)、锌(P=0.005)、白蛋白(P<0.05)。
  • 3个非相关变量的多因素分析中,锌水平(OR=0.0001,P=0.03)为SIBO唯一独立预测因子(模型C统计量=0.89,P<0.001)。

关键数值与推荐

  • 慢性胰腺炎定义:Mayo评分(0-16分)≥4分。
  • SIBO定义:按罗马共识标准,葡萄糖呼气试验阳性。
  • 锌水平与SIBO独立相关:OR=0.0001,P=0.03。
  • 模型C统计量=0.89,P<0.001。

临床怎么用

  • 作者认为,慢性胰腺炎患者中更严重疾病标志(低锌水平、糖尿病和Mayo评分升高)及阿片类药物使用应提高对SIBO的临床怀疑,尤其在持续脂肪泻或体重下降且接受胰腺酶替代治疗的患者中。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Small intestinal bacterial overgrowth (SIBO) is often present in patients with chronic pancreatitis (CP) with persistent steatorrhea, despite pancreatic enzyme replacement therapy. Overall prevalence of SIBO, diagnosed by glucose breath test (GBT), varies between 0% and 40% but 0%-21% in those without upper gastrointestinal (GI) surgery. We investigated the prevalence and nonsurgical independent predictors of SIBO in CP without upper GI surgery. METHODS: Two hundred seventy-three patients ≥18 years old had a presumptive diagnosis of CP and a GBT between 1989 and 2017. We defined CP by Mayo score (0-16) ≥4 and a positive GBT for SIBO by Rome consensus criteria and retrospectively collected data for 5 a priori variables (age, opiates, alcohol use, diabetes mellitus (DM), gastroparesis) and 41 investigational variables (demographics, GI symptoms, comorbidities, CP etiologies and cofactors, CP symptom duration, Mayo score and nondiabetes components, and biochemical variables). RESULTS: Ninety-eight of 273 patients had definite CP and 40.8% had SIBO. Five of 46 variables predicted SIBO: opiates, P = 0.005; DM, P = 0.04; total Mayo score, P < 0.05; zinc, P = 0.005; and albumin, P < 0.05). Multivariable analysis of 3 noncorrelated variables identified zinc level (odds ratio = 0.0001; P = 0.03) as the sole independent predictor of SIBO (model C-statistic = 0.89; P < 0.001). DISCUSSION: SIBO, diagnosed by GBT, occurs in 40.8% of patients with CP without upper GI surgery. In patients with CP, markers of more severe CP (low zinc level, DM and increased Mayo score) and opiate use should raise clinical suspicion for SIBO, particularly in patients with persistent steatorrhea or weight loss despite pancreatic enzyme replacement therapy.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Lee AA, Baker JR, Wamsteker EJ, et al. Small Intestinal Bacterial Overgrowth Is Common in Chronic Pancreatitis and Associates With Diabetes, Chronic Pancreatitis Severity, Low Zinc Levels, and Opiate Use. Am J Gastroenterol. 2019. PMID: 31008737. doi:10.14309/ajg.0000000000000200

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。